Nectero Therapeutics Reports Two-Year Safety and Efficacy Data from First-in-Human Trial for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms
The results were presented at Charing Cross 2026 by Dr. [...]
The results were presented at Charing Cross 2026 by Dr. [...]
The study’s PI is Michael Lo, M.D., a leading plastic [...]
Mechanical Thrombectomy Dramatically Outperforms Standard PE Care at 90 Days [...]
On March 12, 2026, the first implant of the ProStyle M® [...]
Company Appoints D. Keith Grossman to Board of Directors The [...]
Mechanism-Driven Study Design Focused on Capital Efficiency and Accelerated Development [...]
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical [...]
The study, published in The March 2026 edition of Federal [...]
The Journal of the American Medical Association (JAMA Neurology) publication [...]
Verve Medical, the leader in non‑invasive renal pelvic denervation (RPD) [...]